Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

In STSD patients, the body compensates for low androgen levels by increasing another enzyme's activity.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

Testosterone affects hair loss, acne, and excessive hair growth, and antiandrogens can help treat these conditions.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

Higher testosterone and DHEA-S levels may be linked to male pattern baldness.

Beard hair follicles convert testosterone to 5α-dihydrotestosterone most intensively.

A new method was developed to analyze certain hormones and drugs in human blood efficiently.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

Daily subcutaneous testosterone effectively restores testosterone levels in men.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

A woman's excessive hair growth was linked to a rare case of high testosterone caused by a prolactin-producing pituitary tumor.

Testosterone levels are not linked to erectile dysfunction in young and middle-aged men with HIV.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Male children's genital development issues can be caused by genetic mutations or environmental factors affecting hormone action.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.